DHEA-S: Evidence-Based Ways to Improve This Number

What DHEA-S Actually Measures

DHEA-S is the sulfated storage form of DHEA, the most abundant steroid hormone in human circulation. Your adrenal glands produce over 95% of it. The sulfate group makes DHEA-S water-soluble and extends its half-life to 10-20 hours, compared to roughly 30 minutes for unconjugated DHEA [1]. This long half-life means a single blood draw gives a stable, reliable snapshot of your adrenal androgen output without the pulsatile fluctuations that complicate cortisol measurement.

DHEA-S serves as a precursor pool. Peripheral tissues convert it into active androgens (testosterone, dihydrotestosterone) and estrogens (estradiol, estrone) through enzymes like steroid sulfatase and 3-beta-hydroxysteroid dehydrogenase [2]. The clinical value of measuring DHEA-S lies in its ability to reflect both adrenal function and the body's reservoir for downstream sex hormone production. An abnormally high value can signal an adrenal tumor, congenital adrenal hyperplasia, or polycystic ovary syndrome (PCOS). A low value may indicate adrenal insufficiency, hypopituitarism, or age-related adrenal decline, sometimes called "adrenopause."

The Endocrine Society considers DHEA-S one of the most age-sensitive biomarkers in endocrinology [3]. Levels rise sharply during adrenarche (ages 6-8), peak between ages 20 and 25, and then decline by approximately 2-3% per year. By age 70-80, most adults have DHEA-S levels 10-20% of their youthful peak [1].

Normal DHEA-S Ranges by Age and Sex

Reference ranges vary by laboratory assay, but the general pattern is consistent: values are highest in young adults and decline steadily with age. The following ranges, based on immunoassay data compiled by major reference laboratories, offer a working framework [4].

For women, typical DHEA-S values run approximately 65-380 mcg/dL at ages 20-29, 45-270 mcg/dL at ages 30-39, 32-240 mcg/dL at ages 40-49, 26-200 mcg/dL at ages 50-59, and 13-130 mcg/dL at ages 60-69. For men, ranges are higher: 280-640 mcg/dL at ages 20-29, 120-520 mcg/dL at ages 30-39, 95-530 mcg/dL at ages 40-49, 70-310 mcg/dL at ages 50-59, and 42-290 mcg/dL at ages 60-69 [4].

Context matters. A 55-year-old woman with a DHEA-S of 40 mcg/dL is within her age-adjusted reference range but sits at the lower end. Whether that level warrants intervention depends on symptoms, goals, and the clinical picture rather than on the number alone.

Evidence-Based Strategies to Raise Low DHEA-S

Low DHEA-S is far more common than high DHEA-S, especially after age 40. Raising it involves a combination of direct supplementation and lifestyle optimization. The evidence base varies by intervention.

Oral DHEA Supplementation

This is the most direct, most studied approach. Oral DHEA (the over-the-counter supplement in the United States, regulated as a prescription medication in much of Europe) reliably increases circulating DHEA-S levels within days. A landmark 1994 study by Morales et al. demonstrated that 50 mg/day of oral DHEA for six months restored DHEA-S to youthful concentrations in men and women aged 40-70. Physical and psychological well-being scores improved significantly in women (P=0.005) [5].

Dosing ranges in published trials span 25 mg to 200 mg per day, but most clinicians recommend starting at 25-50 mg/day for women and 50-100 mg/day for men [6]. The Endocrine Society's 2014 guidelines on androgen therapy note that DHEA supplementation in women with adrenal insufficiency can improve well-being and libido, though the Society did not recommend routine use in healthy aging populations due to inconsistent data across outcomes [3].

A 2013 Cochrane review of DHEA supplementation in postmenopausal women found no consistent benefit for cognition, well-being, or sexual function across pooled trials, but individual trials with appropriate patient selection (e.g., adrenal insufficiency, documented low DHEA-S) showed benefit [7]. The discrepancy highlights a key clinical point: DHEA supplementation works best when you are genuinely deficient, not as a performance enhancer in people with normal levels.

Exercise

Resistance training and high-intensity interval training (HIIT) both increase DHEA-S acutely and, with consistent practice, may raise baseline levels over weeks to months. A 2017 randomized controlled trial in older men (ages 65-75, N=45) found that 12 weeks of progressive resistance training three times per week increased resting DHEA-S by 14.5% (P<0.05) compared to sedentary controls [8]. Aerobic exercise at moderate intensity has shown more modest effects in most studies, but a 2020 meta-analysis of exercise interventions in older adults (eight RCTs, N=572) confirmed that structured exercise programs of at least eight weeks raised DHEA-S by a pooled mean of 9.2% [9].

The mechanism likely involves acute hypothalamic-pituitary-adrenal (HPA) axis activation during training, plus long-term improvements in insulin sensitivity that reduce adrenal suppression.

Stress Reduction

Chronic psychological stress suppresses DHEA-S through sustained cortisol elevation and HPA axis dysregulation. High cortisol-to-DHEA-S ratios correlate with depression, anxiety, and accelerated biological aging in multiple observational studies [10]. Interventions that lower cortisol may allow DHEA-S recovery. A 2013 RCT of mindfulness-based stress reduction (MBSR) in chronically stressed adults (N=57) found that eight weeks of MBSR reduced cortisol AUC by 12% and raised DHEA-S by 8.7% compared to waitlist controls, improving the cortisol-to-DHEA-S ratio significantly (P=0.03) [10].

Practical approaches include structured meditation (15-30 minutes daily), cognitive behavioral therapy for chronic stress, and reducing unnecessary stressors where possible. Sleep quality plays a role here as well.

Sleep Optimization

DHEA-S secretion follows circadian patterns influenced by sleep architecture. Short sleep duration (<6 hours per night) is associated with lower DHEA-S in cross-sectional studies. A 2015 analysis from the CARDIA cohort (N=370) showed that each additional hour of objective sleep duration (measured by actigraphy) was associated with 4.2 mcg/dL higher DHEA-S after adjusting for age, BMI, and sex [11]. While this is observational data, the physiological rationale is sound: adequate sleep supports healthy HPA axis recovery and reduces catabolic cortisol exposure.

Target seven to nine hours per night. Prioritize sleep consistency (same bed and wake times) over total duration alone.

Caloric Adequacy and Micronutrients

Severe caloric restriction suppresses adrenal androgen output. This is well documented in anorexia nervosa, where DHEA-S levels are markedly low and recover with nutritional rehabilitation [12]. Beyond caloric intake, specific micronutrient deficiencies may impair DHEA-S production. Vitamin D status correlates positively with DHEA-S in large epidemiologic datasets. A 2012 cross-sectional analysis of NHANES participants (N=2,006) found that each 10 ng/mL increase in serum 25-hydroxyvitamin D was associated with a 7.8% higher DHEA-S (P<0.01) [13]. Zinc, magnesium, and vitamin B6 also participate in adrenal steroidogenesis, though randomized data directly linking their supplementation to DHEA-S increases are limited.

How to Lower Elevated DHEA-S

High DHEA-S requires a diagnosis before a treatment plan, because the cause determines the approach. The three most common causes of elevated DHEA-S in clinical practice are PCOS, non-classic congenital adrenal hyperplasia (NCCAH), and adrenal tumors.

PCOS-Related Elevation

Roughly 20-30% of women with PCOS have elevated DHEA-S, reflecting adrenal androgen excess rather than (or in addition to) ovarian hyperandrogenism [14]. The Endocrine Society's 2013 PCOS diagnostic guidelines recommend measuring DHEA-S as part of the hyperandrogenism workup when total or free testosterone is inconclusive [15].

Treatment options that reduce DHEA-S in PCOS include combined oral contraceptives (COCs), which suppress both ovarian and adrenal androgen production through gonadotropin and ACTH modulation. Metformin (1,500-2 to 000 mg/day) improves insulin sensitivity and can lower DHEA-S by 15-25% in insulin-resistant PCOS patients, as shown in a 2009 meta-analysis of 12 RCTs (N=543) [16]. Spironolactone (50-200 mg/day), while primarily an androgen receptor blocker, may modestly reduce DHEA-S in some patients.

Non-Classic Congenital Adrenal Hyperplasia

NCCAH due to 21-hydroxylase deficiency often presents with high DHEA-S alongside elevated 17-hydroxyprogesterone. Low-dose glucocorticoids (hydrocortisone 10-15 mg/day or dexamethasone 0.25-0.5 mg at bedtime) suppress excess adrenal androgen production by reducing ACTH drive. The 2018 Endocrine Society guidelines for CAH management recommend against routine glucocorticoid treatment in asymptomatic NCCAH, reserving it for patients with bothersome hyperandrogenic symptoms or infertility [17].

Adrenal Tumors

An isolated, markedly elevated DHEA-S (often exceeding 600-700 mcg/dL regardless of age) with rapid symptom onset warrants imaging. Adrenal adenomas or carcinomas can autonomously secrete DHEA-S. Surgical resection is the primary treatment for functioning adrenal tumors. This is not a situation for lifestyle modification.

Monitoring and Retesting

After starting any DHEA-S-targeted intervention, recheck levels at 6-8 weeks. Oral DHEA supplementation reaches steady-state DHEA-S within one to two weeks, but downstream effects on testosterone, estradiol, and symptoms take four to eight weeks to manifest [6]. For lifestyle interventions (exercise, sleep, stress reduction), allow at least 8-12 weeks before expecting measurable lab changes.

When retesting, draw blood in the morning (before 10 AM) for consistency, though DHEA-S is less diurnal than cortisol. Request DHEA-S specifically, not unconjugated DHEA, which has high intraindividual variability. If you are supplementing with oral DHEA, take your dose after the blood draw to avoid measuring a post-absorption peak rather than your true baseline.

Track not just the number but the clinical picture. DHEA-S is a means to an end. The relevant outcomes are energy, body composition, libido, mood, bone density, and cardiovascular risk markers, not the DHEA-S value in isolation.

DHEA-S and Specific Clinical Populations

Women with Adrenal Insufficiency

DHEA replacement has the strongest evidence base in this population. A 2009 RCT (N=106) of 50 mg daily DHEA in women with primary or secondary adrenal insufficiency (Addison's disease or hypopituitarism) showed improvements in health-related quality of life, depression scores, and sexual function over 12 months compared to placebo [18]. The European Society of Endocrinology guidelines suggest a trial of DHEA 25-50 mg/day in women with adrenal insufficiency who have impaired well-being despite optimized glucocorticoid and mineralocorticoid replacement [19].

Aging Men on TRT Evaluation

In men being evaluated for testosterone replacement therapy, a low DHEA-S can add context. It suggests the low testosterone is partly adrenal in origin rather than purely gonadal. Some clinicians add low-dose DHEA (25-50 mg/day) alongside TRT to replenish the adrenal androgen pool, though no large RCTs have tested this combination strategy against TRT alone. The rationale is physiologic: restoring both gonadal and adrenal androgen contributions may better approximate the hormonal milieu of a younger man.

Perimenopausal and Postmenopausal Women

The DHEA-S decline accelerates during the menopausal transition. Intravaginal DHEA (prasterone, brand name Intrarosa, 6.5 mg daily) received FDA approval in 2016 for moderate-to-severe dyspareunia due to vulvovaginal atrophy [20]. This formulation acts locally, converting DHEA to estrogens and androgens within vaginal tissue, with minimal systemic absorption. It is distinct from oral DHEA supplementation and does not meaningfully raise serum DHEA-S levels.

Safety Considerations for DHEA Supplementation

Oral DHEA is generally well tolerated at doses of 25-50 mg/day, but it is not risk-free. Because DHEA converts to both androgens and estrogens, side effects can go in either direction. Women may experience acne, hirsutism, scalp hair thinning, or voice deepening at higher doses. Men may experience gynecomastia if aromatization to estradiol is significant [6].

The American Academy of Anti-Aging Medicine and several integrative medicine societies recommend monitoring serum DHEA-S, testosterone (total and free), estradiol, and PSA (in men) every three to six months during supplementation [6]. DHEA is classified as a dietary supplement in the United States and is not subject to FDA pharmaceutical-grade manufacturing standards. Quality varies between brands. Third-party-tested products (USP-verified or NSF-certified) are preferable.

DHEA is banned by the World Anti-Doping Agency (WADA) and most professional sports organizations because it is a direct precursor to anabolic steroids [21]. Athletes subject to drug testing should avoid it entirely.

Contraindications include hormone-sensitive cancers (breast, prostate, endometrial) or a strong family history of these cancers, given DHEA's conversion to sex steroids. A 2006 prospective cohort analysis from the Women's Health Initiative (N=272) found no increased breast cancer risk with higher endogenous DHEA-S levels after adjusting for BMI and estradiol, but the authors cautioned that exogenous supplementation was not studied [22].

When to See a Specialist

A primary care provider can order and interpret DHEA-S for most situations. Referral to an endocrinologist is appropriate when DHEA-S exceeds 600 mcg/dL in a woman or 700 mcg/dL in a man (to rule out adrenal neoplasm), when clinical signs of Cushing syndrome or virilization accompany the lab abnormality, when NCCAH is suspected (obtain a cosyntropin stimulation test with 17-OHP measurement), or when DHEA-S remains persistently low despite supplementation, suggesting impaired adrenal reserve requiring further workup with ACTH stimulation testing.

The cortisol-to-DHEA-S molar ratio, while not yet standardized across laboratories, is an emerging metric. Ratios above 0.2 have been associated with increased mortality in critically ill patients and with depression severity in outpatient psychiatric populations [10]. Ask your clinician whether this ratio adds useful information to your specific clinical scenario.

Recheck DHEA-S at 6-8 weeks after any intervention change, fasting, before 10 AM, and prior to that day's DHEA dose if supplementing.